Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
Substituted quinoxaline carboxylic acids for the inhibition of PASK
申请人:McCall John M.
公开号:US08912188B2
公开(公告)日:2014-12-16
Disclosed herein are substituted quinoxaline carboxylic acids of Formula (I):
and compositions thereof, which may be useful as inhibitors of PAS Kinase (PASK) activity in a human or animal for the treatment of diseases such as diabetes mellitus.